By moving chronic care management from occasional visits to daily RPM, the Michigan health system has significantly improved outcomes for diabetes, heart failure and hypertension patients. Its ...
Abbott Laboratories is back in focus as fresh research feeds into updated price targets, with several firms clustering their ...
Meta’s Muse Spark model offers to analyze users’ health data, including lab results. Beyond the obvious privacy risks, it’s ...
Explore the daily duties of pharmacists across different healthcare settings, and learn about the educational pathways ...
What is the best way to handle cellphones in schools? That’s a question Michigan educators are grappling with this spring ...
Study of 2,197 patients with resistant depression finds 95 percent improved once parasympathetic and sympathetic ...
Ultragenyx (RARE) outlook: rare-disease pipeline with 2026–2027 catalysts (GTX-102, DTX401, UX111) and $1.5B–$2.4B peak sales ...
Mobi Health is right in the middle of this shift, making it way easier for folks to stay on top of their health without ...
MIT's new device uses light to measure blood sugar levels without any needles, and a wearable version is already in the works ...
Abbott Laboratories (NYSE: ABT) and Dexcom (NASDAQ: DXCM) are two leading medical device companies that compete against one ...